Sotac Pharmaceuticals logo

Sotac Pharmaceuticals

SOTAC NSE
₹90.05 0.00 (0.00%)
Market Cap
₹99.50 Cr
P/E
22.51

Key Fundamentals

SMEPharmaceuticalsHealthcare
Market Cap
₹99.50 Cr
P/E (TTM)
22.51
EBITDA
₹18.20 Cr
Return on Equity
9.75%
Debt to Equity
0.64
Book Value
₹53.28
EPS (TTM)
₹4.00
52W High
₹139.65
52W Low
₹86.00

Price-based figures as of 13 Oct 2026, 11:17 IST · TTM

Peer Comparison

Healthcare › Pharmaceuticals

Sun Pharma
₹1,770.7035.134,24,850 Cr5.080.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,285.0084.272,46,488 Cr14.710.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,642.9072.891,76,601 Cr21.000.82%12.16%9.06%15,391 Cr2,156 Cr
Zydus Life Science
₹1,132.5025.201,12,967 Cr4.170.09%16.99%19.24%28,515 Cr4,593 Cr
Laurus Labs
₹2,059.40101.751,11,272 Cr21.000.10%16.38%19.67%7,323 Cr1,090 Cr
Cipla
₹1,329.6031.851,07,413 Cr3.121.00%11.21%14.88%28,786 Cr3,356 Cr
Dr Reddys Laboratories
₹1,240.0032.121,03,500 Cr2.720.67%10.87%13.94%34,555 Cr3,184 Cr
Mankind Pharma
₹2,372.0047.9597,974 Cr6.010.04%11.70%13.78%15,074 Cr2,067 Cr
Aurobindo Pharma
₹1,684.6026.2896,928 Cr2.560.24%9.25%13.58%35,390 Cr3,711 Cr
Lupin
₹1,953.6016.1589,336 Cr3.980.92%23.79%28.42%30,017 Cr5,552 Cr
Sotac Pharmaceuticals (this company)
₹90.0522.51100 Cr1.690.22%9.75%17.07%106 Cr5 Cr
Median 11 companies₹1,770.7032.121,07,413 Cr4.170.32%12.16%17.07%28,515 Cr3,184 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

No Tapetide Score has been computed for this stock yet.

Key Insights

Strengths

1
  • Company has delivered good profit growth of 34.5% CAGR over last 5 years

Weaknesses

1
  • Company has a low return on equity of 12.8% over last 3 years.

Technical Indicators

Oscillators

BearishNeutralBullish

Neutral

Bearish
2
Neutral
5
Bullish
2

Overall

BearishNeutralBullish

Bearish

Bearish
12
Neutral
5
Bullish
2

Moving Averages

BearishNeutralBullish

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
0.69% lower than 3Y

change over 1 year

Net Income Growth
-32.26% lower than 3Y

change over 1 year

Cash Flow Change
487%

change over 1 year

EBITDA Margin Change
3.28%

change over 1 year Operating margin 17% · Mar 2026

Quarterly Results

Particulars Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
40
38
52
52
53
47
37
60
Expenses
36
34
47
48
48
35
33
50
Operating Profit
3
4
4
4
4
12
4
10
OPM %
9%
10%
9%
8%
8%
26%
10%
17%
Other Income
1
0
0
0
1
0
4
0
Interest
1
1
1
1
1
2
2
2
Depreciation
1
1
1
2
1
2
3
3
PBT
2
2
2
2
3
9
3
5
Tax %
49%
34%
45%
-34%
30%
13%
23%
31%
Net Profit
2
1
2
3
2
6
2
3
EPS (₹)
6.78
1.64
1.57
2.31
1.73
5.53
2.22
3
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2020Mar 2021Mar 2023Mar 2024Mar 2025Mar 2026
Sales
29
49
77
104
100
101
Expenses
27
47
70
95
83
83
Operating Profit
2
1
7
9
16
18
OPM %
7%
3%
10%
8%
16%
18%
Other Income
0
0
1
0
1
0
Interest
0
1
2
2
3
4
Depreciation
1
3
2
3
4
5
PBT
0
-2
4
4
11
9
Tax %
75%
15%
42%
10%
17%
28%
Net Profit
0
-2
2
4
9
6
EPS (₹)
0.39
-10.3
3.58
3.87
7.27
5.22
Div. Payout %
0%
0%
0%
0%
0%
4%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2020Mar 2021Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
2
2
8
11
11
11
Reserves
1
0
11
34
42
48
Borrowings
13
17
22
25
44
38
Other Liabilities
14
15
32
35
27
37
Total Liabilities
30
35
74
105
124
133
Fixed Assets
16
17
26
36
49
50
CWIP
0
0
0
5
0
2
Investments
0
0
0
2
4
3
Other Assets
14
18
48
63
72
79
Total Assets
30
35
74
105
124
133
Figures in ₹ Crores

Cash Flow

Particulars Mar 2020Mar 2021Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0
0
8
-16
-4
17
Investing
-12
-3
-12
-20
-14
-7
Financing
11
3
13
29
16
-10
Net Cash Flow
0
0
10
-6
-2
0
Free Cash Flow
-10
-3
0
-34
-16
9
CFO/OP
17
8
134
-168
-22
106
Figures in ₹ Crores

Ratios

Particulars Mar 2020Mar 2021Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
89
44
70
92
125
119
Inventory Days
40
45
87
83
108
153
Days Payable
194
121
162
132
101
154
Cash Conversion Cycle
-66
-32
-5
43
132
119
Working Capital Days
-79
-44
-40
47
61
66
ROCE %
—
-5%
—
10%
15%
12%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Sotac Pharmaceuticals insights

55 extracted metrics + investor summaries across FY20–FY26.

Log in — free

Shareholding Pattern

Others3.84%Promot.72.85%Public6.52%FIIs16.79%As ofMar 2026

Documents

Frequently Asked Questions about Sotac Pharmaceuticals

What does Sotac Pharmaceuticals Ltd do?
Incorporated in 2015, Sotac Pharmaceuticals Ltd manufactures and sells a wide range of pharmaceutical products[1]
Where is Sotac Pharmaceuticals Ltd (SOTAC) listed?
Sotac Pharmaceuticals Ltd trades as SOTAC on the NSE.
Which sector does Sotac Pharmaceuticals Ltd belong to?
Sotac Pharmaceuticals Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Sotac Pharmaceuticals Ltd?
Sotac Pharmaceuticals Ltd has a market capitalisation of ₹99.5 Cr as of 13 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Sotac Pharmaceuticals Ltd?
Sotac Pharmaceuticals Ltd trades at a PE ratio of 22.51 as of 13 Oct 2026, on earnings per share of ₹4, against a book value of ₹53.28 per share.
What is the 52-week high and low of Sotac Pharmaceuticals Ltd?
Over the last 52 weeks Sotac Pharmaceuticals Ltd has traded between ₹86 and ₹139.65 as of 13 Oct 2026.
Does Sotac Pharmaceuticals Ltd pay dividends?
Sotac Pharmaceuticals Ltd has a dividend yield of 0.22%.
What is the Return on Equity (ROE) of Sotac Pharmaceuticals Ltd?
Sotac Pharmaceuticals Ltd reported a return on equity of 9.75%. Its debt-to-equity ratio is 0.64.

Company Information

Incorporated in 2015, Sotac Pharmaceuticals Ltd manufactures and sells a wide range of pharmaceutical products[1]

Website sotacpharma.com
Listed 2023-04-13
Face Value ₹ 10
Shares Outstanding 1,10,49,417

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SOTAC.md for Sotac Pharmaceuticals Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List